Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,884,146 papers from all fields of science
Search
Sign In
Create Free Account
GP 140
Known as:
GP-140
, GP140
, glycoprotein 140
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Glycoproteins
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap
G. Gray
,
K. Mayer
,
+17 authors
A. Williamson
Clinical and Vaccine Immunology
2016
Corpus ID: 2685501
ABSTRACT A phase I safety and immunogenicity study investigated South African AIDS Vaccine Initiative (SAAVI) HIV-1 subtype C…
Expand
2014
2014
Glycosylation and Disulfide Bond Analysis of Transiently and Stably Expressed Clade C HIV-1 gp140 Trimers in 293T Cells Identifies Disulfide Heterogeneity Present in Both Proteins and Differences in…
Eden P. Go
,
David C. Hua
,
H. Desaire
Journal of Proteome Research
2014
Corpus ID: 17675500
The HIV-1 envelope protein (Env) mediates viral entry into host cells to initiate infection and is the sole target of antibody…
Expand
Highly Cited
2011
Highly Cited
2011
Phase I Randomised Clinical Trial of an HIV-1CN54, Clade C, Trimeric Envelope Vaccine Candidate Delivered Vaginally
D. Lewis
,
C. Fraser
,
+11 authors
C. Lacey
PLoS ONE
2011
Corpus ID: 1947256
We conducted a phase 1 double-blind randomised controlled trial (RCT) of a HIV-1 envelope protein (CN54 gp140) candidate vaccine…
Expand
2003
2003
Induction of Primary Virus-Cross-Reactive Human Immunodeficiency Virus Type 1-Neutralizing Antibodies in Small Animals by Using an Alphavirus-Derived In Vivo Expression System
M. Dong
,
P. Zhang
,
+10 authors
G. Quinnan,
Journal of Virology
2003
Corpus ID: 22108042
ABSTRACT We have studied the induction of neutralizing antibodies by in vivo expression of the human immunodeficiency virus type…
Expand
Highly Cited
2000
Highly Cited
2000
Immunization of Cats against Feline Immunodeficiency Virus (FIV) Infection by Using Minimalistic Immunogenic Defined Gene Expression Vector Vaccines Expressing FIV gp140 Alone or with Feline…
C. Leutenegger
,
F. Boretti
,
+10 authors
H. Lutz
Journal of Virology
2000
Corpus ID: 19815691
ABSTRACT Four groups of cats, each containing four animals, were immunized at 0, 3, and 6 weeks with minimalistic immunogenic…
Expand
Highly Cited
1996
Highly Cited
1996
In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope
Paul W H I Parren
,
Paola Fisicaro
,
+5 authors
D. R. Burton
Journal of Virology
1996
Corpus ID: 2736442
Human antibody responses, or versions thereof, can be cloned as phage display libraries. In vaccine evaluation, the possibility…
Expand
Highly Cited
1985
Highly Cited
1985
Bovine coronavirus hemagglutinin protein
B. King
,
B. Potts
,
D. Brian
Virus Research
1985
Corpus ID: 21185994
Highly Cited
1984
Highly Cited
1984
Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein.
Charles Grose
,
Dean P. Edwards
,
Kristen A. Weigle
,
W. Friedrichs
,
William L. McGuire
Virology
1984
Corpus ID: 25255231
Highly Cited
1982
Highly Cited
1982
The cooperative role of the transformation-sensitive glycoproteins, GP140 and fibronectin, in cell attachment and spreading.
W. Carter
Journal of Biological Chemistry
1982
Corpus ID: 12869261
The detergent-insoluble matrix of cultured human fibroblasts contains cytoskeletal and nuclear components, as well as two major…
Expand
Highly Cited
1982
Highly Cited
1982
Transformation-dependent alterations is glycoproteins of extracellular matrix of human fibroblasts. Characterization of GP250 and the collagen-like GP140.
W. Carter
Journal of Biological Chemistry
1982
Corpus ID: 22901390
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE